Procept Biorobotics Corp (PRCT) Annual Income Statement (USD)
PRCT Quarterly Financials (USD)
Frequently Asked Questions About Procept Biorobotics Corp (PRCT) Stock
Procept Biorobotics Corp's (PRCT) last reported annual revenue was USD 136.19 Million.
Procept Biorobotics Corp's (PRCT) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Procept Biorobotics Corp's(PRCT) is not profitable as of its last reported annual financials.
The net profit margin for Procept Biorobotics Corp's(PRCT) from its laster reported year is -77.76%
The return on equity (ROE) for Procept Biorobotics Corp's(PRCT) from its last reported annual financials is : -44.33%
The return on assets (ROA) for Procept Biorobotics Corp's(PRCT) from its last reported annual financials is : -19.11%
The return on invested capital (ROIC) for Procept Biorobotics Corp's(PRCT) from its last reported annual financials is : -37.62%
The Debt to Equity ratio for Procept Biorobotics Corp's(PRCT) from its last reported annual financials is : 18.29%
The dividend yield for Procept Biorobotics Corp's(PRCT) from its laster reported year is 0.00%
Procept Biorobotics Corp's(PRCT) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PRCT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
